Yasin Folkvaljon

1.4k total citations
37 papers, 947 citations indexed

About

Yasin Folkvaljon is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yasin Folkvaljon has authored 37 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 10 papers in Oncology. Recurrent topics in Yasin Folkvaljon's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Global Cancer Incidence and Screening (6 papers). Yasin Folkvaljon is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (19 papers) and Global Cancer Incidence and Screening (6 papers). Yasin Folkvaljon collaborates with scholars based in Sweden, United States and United Kingdom. Yasin Folkvaljon's co-authors include Pär Stattin, Stacy Loeb, David Robinson, Ola Bratt, Mats Lambe, Hans Garmo, Ingela Franck Lissbrant, Danil V. Makarov, Caitlin Curnyn and Annelies Vellekoop and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Yasin Folkvaljon

37 papers receiving 935 citations

Peers

Yasin Folkvaljon
Amy L. Tin United States
Franz Recker Switzerland
Raymond Lance United States
Dattatraya Patil United States
Patricia K. Landis United States
Amy L. Tin United States
Yasin Folkvaljon
Citations per year, relative to Yasin Folkvaljon Yasin Folkvaljon (= 1×) peers Amy L. Tin

Countries citing papers authored by Yasin Folkvaljon

Since Specialization
Citations

This map shows the geographic impact of Yasin Folkvaljon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasin Folkvaljon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasin Folkvaljon more than expected).

Fields of papers citing papers by Yasin Folkvaljon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasin Folkvaljon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasin Folkvaljon. The network helps show where Yasin Folkvaljon may publish in the future.

Co-authorship network of co-authors of Yasin Folkvaljon

This figure shows the co-authorship network connecting the top 25 collaborators of Yasin Folkvaljon. A scholar is included among the top collaborators of Yasin Folkvaljon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasin Folkvaljon. Yasin Folkvaljon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lissbrant, Ingela Franck, Eugenio Ventimiglia, David Robinson, et al.. (2018). Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden. Scandinavian Journal of Urology. 52(2). 143–150. 12 indexed citations
2.
Joneborg, Ulrika, Yasin Folkvaljon, Nikos Papadogiannakis, Mats Lambe, & Lena Marions. (2018). Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study. Acta Oncologica. 57(8). 1094–1099. 20 indexed citations
3.
Wulaningsih, Wahyu, Hans Garmo, Johan Ahlgren, et al.. (2018). Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity. Breast Cancer Research and Treatment. 172(1). 167–177. 35 indexed citations
4.
Folkvaljon, Yasin, et al.. (2018). Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden. Scandinavian Journal of Urology. 52(4). 277–284. 6 indexed citations
5.
Loeb, Stacy, Yasin Folkvaljon, Jan‐Erik Damber, et al.. (2017). Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer. Journal of Clinical Oncology. 35(13). 1430–1436. 55 indexed citations
6.
Loeb, Stacy, Eugenio Ventimiglia, Andrea Salonia, Yasin Folkvaljon, & Pär Stattin. (2017). Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma. JNCI Journal of the National Cancer Institute. 109(8). 21 indexed citations
7.
Folkvaljon, Yasin, et al.. (2017). Long‐term adverse effects after retropubic and robot‐assisted radical prostatectomy. Nationwide, population‐based study. Journal of Surgical Oncology. 116(4). 500–506. 12 indexed citations
8.
Birgegård, Gunnar, Yasin Folkvaljon, Hans Garmo, et al.. (2016). Rate Of Malignant Transformation In High Risk Et During 5 Years Of Follow-Up Of Cytoreductive Therapy. Haematologica. 101. 96–96. 1 indexed citations
9.
Folkvaljon, Yasin, J. Sundberg, Mats Lambe, et al.. (2016). VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR MYELODYSPLASTIC SYNDROMES IN THE SWEDISH MDS-REGISTER. Haematologica. 101. 243–243. 1 indexed citations
10.
Folkvaljon, Yasin, Per Nilsson, David Robinson, et al.. (2016). Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scandinavian Journal of Urology. 50(5). 338–345. 15 indexed citations
11.
Folkvaljon, Yasin, et al.. (2016). Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy. Scandinavian Journal of Urology. 50(3). 155–159. 8 indexed citations
12.
Loeb, Stacy, Yasin Folkvaljon, Caitlin Curnyn, et al.. (2016). Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden. JAMA Oncology. 3(10). 1393–1393. 118 indexed citations
13.
Loeb, Stacy, Yasin Folkvaljon, Mats Lambe, et al.. (2015). Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma. JAMA. 313(24). 2449–2449. 66 indexed citations
14.
Bratt, Ola, Yasin Folkvaljon, Olof Akre, et al.. (2015). Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer. European Urology. 68(1). 53–58. 64 indexed citations
15.
Loeb, Stacy, Yasin Folkvaljon, David Robinson, et al.. (2015). Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort. European Urology. 69(6). 1135–1141. 88 indexed citations
16.
Loeb, Stacy, Yasin Folkvaljon, David Robinson, et al.. (2015). Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment. European Urology. 70(5). 824–828. 22 indexed citations
17.
Loeb, Stacy, Yasin Folkvaljon, Mats Lambe, et al.. (2015). 131 Do PDE5 inhibitors increase the risk of malignant melanoma?. European Urology Supplements. 14(2). e131–e131. 1 indexed citations
18.
Loeb, Stacy, Yasin Folkvaljon, Danil V. Makarov, et al.. (2014). Five-year Nationwide Follow-up Study of Active Surveillance for Prostate Cancer. European Urology. 67(2). 233–238. 72 indexed citations
19.
Loeb, Stacy, Yasin Folkvaljon, Dmitrii E. Makarov, et al.. (2014). 29 Active surveillance in the National Prostate Cancer Register (NPCR) of Sweden: Patterns of care and outcomes after 5 years of follow-up. European Urology Supplements. 13(1). e29–e29. 1 indexed citations
20.
Vellekoop, Annelies, Stacy Loeb, Yasin Folkvaljon, & Pär Stattin. (2013). Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer. The Journal of Urology. 191(2). 350–357. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026